As of 2026-06-02, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (48.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.19 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -4210.4%.
The range of the Relative Valuation is (47.82) - (49.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 22.8x | 20.2x |
| Forward P/E multiples | 19.6x - 20.1x | 19.8x |
| Fair Price | (47.82) - (49.04) | (48.91) |
| Upside | -4118.1% - -4220.6% | -4210.4% |
| Date | P/E |
| 2026-05-29 | -0.48 |
| 2026-05-28 | -0.52 |
| 2026-05-27 | -0.54 |
| 2026-05-26 | -0.50 |
| 2026-05-22 | -0.46 |
| 2026-05-21 | -0.47 |
| 2026-05-20 | -0.45 |
| 2026-05-19 | -0.44 |
| 2026-05-18 | -0.46 |
| 2026-05-15 | -0.47 |
| 2026-05-14 | -0.50 |
| 2026-05-13 | -0.49 |
| 2026-05-12 | -0.49 |
| 2026-05-11 | -0.49 |
| 2026-05-08 | -0.50 |
| 2026-05-07 | -0.51 |
| 2026-05-06 | -0.53 |
| 2026-05-05 | -0.51 |
| 2026-05-04 | -0.52 |
| 2026-05-01 | -0.49 |
| 2026-04-30 | -0.50 |
| 2026-04-29 | -0.43 |
| 2026-04-28 | -0.43 |
| 2026-04-27 | -0.45 |
| 2026-04-24 | -0.43 |
| 2026-04-23 | -0.45 |
| 2026-04-22 | -0.47 |
| 2026-04-21 | -0.47 |
| 2026-04-20 | -0.49 |
| 2026-04-17 | -0.47 |
| 2026-04-16 | -0.44 |
| 2026-04-15 | -0.43 |
| 2026-04-14 | -0.43 |
| 2026-04-13 | -0.42 |
| 2026-04-10 | -0.43 |
| 2026-04-09 | -0.44 |
| 2026-04-08 | -0.45 |
| 2026-04-07 | -0.45 |
| 2026-04-06 | -0.47 |
| 2026-04-02 | -0.48 |
| 2026-04-01 | -0.50 |
| 2026-03-31 | -0.55 |
| 2026-03-30 | -0.50 |
| 2026-03-27 | -0.52 |
| 2026-03-26 | -0.56 |
| 2026-03-25 | -0.59 |
| 2026-03-24 | -0.59 |
| 2026-03-23 | -0.60 |
| 2026-03-20 | -0.62 |
| 2026-03-19 | -0.66 |